Mustang Bio MBIO
NASDAQ MBIO
$0.58 +0.01 (+1.96%)
As of: Aug 21, 2026 · 2:30 PM EDT

Mustang Bio (MBIO) Other Non Operating Income (2023)

Mustang Bio (MBIO) posted quarterly Other Non Operating Income of -$2.8 million for Q2 2023.

Mustang Bio (MBIO) Other Non Operating Income (2023) Analysis & Trends

Mustang Bio (MBIO) has reported Other Non Operating Income for 1 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2023.

  • In Q2 2023, Other Non Operating Income changed N/A year-over-year to -$2.8 million; the TTM figure through Sep 2024 stood at -$2.8 million (changed N/A YoY), while the FY2023 annual figure was -$2.8 million, changed N/A from the prior year.
  • Other Non Operating Income was little changed at -$2.8 million in Q2 2023 per MBIO's latest filing.
  • Across five years, Other Non Operating Income topped out at -$2.8 million in Q2 2023 and bottomed at -$2.8 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Mustang Bio 3.90 Mn 3.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -2.80 Mn